Turk Toraks Dergisi, cilt.14, sa.4, ss.152-157, 2013 (ESCI)
OBJECTIVE: The pulmonary function test (PFT) is an important quantification test in the follow-up of sarcoidosis patients. We aimed to investigate the effect of lymphadenopathy (LAP) after controlling pulmonary parenchymal involvement on pulmonary function tests (PFTs) in the context of sarcoidosis.